Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer episode artwork

EPISODE · Nov 23, 2021 · 1H 1M

Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer

from The Long Run with Luke Timmerman · host Timmerman Report

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.

NOW PLAYING

Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer

0:00 1:01:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 1 minute long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on November 23, 2021.

What is this episode about?

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!